Name: Dr. Ashutosh Kumar Assistant Professor ashutosh.niperhyd@gov.in 8008499182 040-23074750

ADDRESS, ROOM NO

Department of Pharmaccology and Toxicology
Room No: 54
NIPER Hyderabad
Department of Pharmaceuticals (Govt. of India)
Balanagar, Hyderabad - 500037, TS, INDIA

Experience

1. HOD , Department of Pharmacology and Toxicology (June 2018-Present) NIPER Hyderabad
2. Assistant Professor (Jan 2013- Present) NIPER Hyderabad
3. Assistant Manager (Jun 2012- Jan 2013) Dr Reddy’s Laboratories
4. Scientific Writer (May 2011- Jun 2012) Novartis Health private limited

QUALIFICATION: (REVERSE CHRONOLOGICAL ORDER)

1. PhD : (2006-2011)
2. M.S (Pham): (2004-2006)
3. B.Pharm : (2000-2004)

COURSES HANDLING(PHD/M.S(PHARM))

PhD:
1. PC 730: Free Radical in Drug Research
2. PC 910 : Diabetes Pathophysiology and discovery of new Drug
MS:
1. PC-530 Experimental Pharmacology
2. PC-540 Chemotherapy of Parasitic and Microbial Infections
3. LG-510 General Laboratory Experience
4. PC-620 CNS and Respiratory Pharmacology
5. PC-650 Clinical Pharmacology and Regulatory Toxicology
6. RT-540 Principles and Methods in Toxicology
7. RT-550 Introduction to Regulatory Toxicology
8. RT- 660 Bioethics
9. LS-610 General Laboratory Experience

PHD STUDENTS/MASTERS STUDENTS

PhD :Submitted: 03 ; Ongoing: 05
MS: Submitted: 30; Ongoing: 8

AWARDS / HONOURS

1. Angelika Bierhaus Award from NEURODIAB
2. DST fast track young scientist
3. PC Dandiya Gold medal at IPS 2007

RESEARCH AREAS/INTEREST

Diabetes and Diabetic complications
Chemotherapy induced Peripheral Neuropathy
Trauma induced Peripheral Neuropathy

SPONSORED PROJECTS

Ongoing extramural projects:
1. DST Funded: (Sanctioned (2017) 23 Lakhs) “Evaluation of Anti-Glycation and Antioxidant Properties of Natural Polyphenolic Compounds in Experimental Models of Diabetic Complications”.
2. DST Funded: (Sanctioned (2017) 48 Lakhs) “Evaluation of neuroprotective effects of AMPK & SIRT1 modulation in experimental diabetic neuropathy using pharmacological approaches”.
3. DBT Funded: (Sanctioned (2018) 99.39 Lakhs) “Evaluation of neuroprotective potential of selected Phytoconstituents on Experimental Diabetic Neuropathy: Focus on Mitochondrial Function and Mitochondrial Biogenesis”.
Completed extra mural projects:
1. DBT Funded : 23.59 lakhs (2014-2017) “Targeting neuroinflammaton, oxidative-nitrosative stress and PARP over activation in experimental model of neuropathic pain”
2. DST Funded : 20.56 lakhs (2014-2016)
“To evaluate the role of AMPK mediated signal transduction in models of chemotherapy induced peripheral neuropathy (CIPN) using pharmacological approaches”.

PUBLICATIONS / BOOK CHAPTERS

1. A Areti, P Koimirishetty, M Akuthota, RA Malik, A Kumar .Journal of Pineal Research 62 (3), e12393 Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy (2017)
2. P Komirishetty, A Areti, R Sistla, R Gogoi, A Kumar Neuropharmacology 113, 137-147. Combination strategy of PARP inhibitor with antioxidant prevents bioenergetic deficits and inflammatory changes in CCI-induced neuropathy ( 2017)
3. VG Yerra, A Kumar Molecular Neurobiology 54 (3), 2301-2312. Adenosine monophosphate-activated protein kinase abates hyperglycaemiainduced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation (2017)
4. P Bachewal, C Gundu, VG Yerra, AK Kalavala, A Areti, A Kumar Biofactors 44 (2), 109-122. Morin Exerts Neuroprotection via Attenuation of ROS Induced Oxidative Damage and Neuroinflammation in Experimental Diabetic Neuropathy (2018)
5. A Areti, P Koimirishetti, AK Kalvala, K Nallaipaneni, A Kumar. Molecular Neurobiology
Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy ( 2018)

PATENTS

NA

INVITED TALKS

1. International: 10
2. National: 25

ADDITIONAL RESPONSIBILITIES

Active member of placement Committee, sports Committee